ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Tesaro's deal struggles? They're actually a good omen for Clovis: analyst
December 20, 2018PARP drugmaker Tesaro may have had a tough time finding a buyer in GlaxoSmithKline. But that doesn’t mean rival Clovis won’t be able to land its own, one analyst says. -
Celgene’s R&D report card ‘somewhat disappointing,' say analysts
May 29, 2018An audit of Celgene’s R&D over the last five years has revealed that two-thirds of its programs failed—and it made no difference whether the project originated in-house or externally.
Pharma Sources Insight January 2025
